| News
The winners of the i4Challenge introduce themselves
05.11.2019
Six companies won the i4Challenge: Arviem, Crevoisier, LCB Sarl, Qiio, Unitelabs and United Planet. We asked the winners to introduce themselves.
David Maître (LCB), Jean-Marie Dubois (Qiio), Philippe Crevoisier (Crevoisier), Simona Androvicsova, Stefan Reidy (Arviem), Katrin Beuthner (United Planet). Not in the picture: Oskari Vinko (UniteLabs) (img: Dave Joly)
Arviem
“Arviem is like the crystal ball of supply chain managers”
Crevoisier
“It’s a great reward, especially for the team”
LCB Sarl
“We have been building Industry 4.0 for more than 25 years. Except that it wasn’t called that way”
Qiio
“Industry 4.0 brings intelligence to machines and processes”
Unitelabs
“We want to empower life scientists with accessible automation they can use every day”
United Planet
“We ease the transition from analogue to digital for every company”
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Moderna driving forward production of vaccine from Basel
Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.
Read More
Yokogawa establishes innovation center in Allschwil
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.
Read More
Basel gains new biotech in Bright Peak
Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.
Read More
Robots from Basel set to revolutionize surgery
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.
Read More
T3 Pharma raises over 25 million Swiss francs
T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.
Read More
Versameb raises 6 million Swiss francs
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.
Read More
Genedata accelerating drug development
Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.
Read More
Basel is “probably the most productive life sciences location in the world”
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.
Read More
Basel Area cantons publish joint economic report
The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.
Read More
Resistell receives high-level EU grant
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.
Read More
